Essex Bio-Technology Limited (HKG:1061)
Hong Kong
· Delayed Price · Currency is HKD 3.190
+0.020 (0.63%)
Apr 29, 2026, 4:08 PM HKT
Essex Bio-Technology Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,809 | 2,138 | 1,667 | 1,413 | 2,401 | 2,848 | Upgrade
|
| Market Cap Growth | -34.09% | 28.20% | 17.98% | -41.13% | -15.72% | 15.63% | Upgrade
|
| Enterprise Value | 1,372 | 1,786 | 1,394 | 1,349 | 2,272 | 2,753 | Upgrade
|
| Last Close Price | 3.19 | 3.77 | 2.86 | 2.32 | 3.83 | 4.41 | Upgrade
|
| PE Ratio | 5.69 | 6.72 | 5.43 | 5.13 | 10.65 | 8.23 | Upgrade
|
| Forward PE | 5.60 | 3.14 | 3.14 | 3.62 | 6.39 | 7.95 | Upgrade
|
| PS Ratio | 1.00 | 1.18 | 1.00 | 0.81 | 1.82 | 1.74 | Upgrade
|
| PB Ratio | 0.75 | 0.89 | 0.79 | 0.74 | 1.39 | 1.64 | Upgrade
|
| P/TBV Ratio | 1.29 | 1.53 | 1.41 | 1.36 | 2.73 | 2.64 | Upgrade
|
| P/FCF Ratio | 9.10 | 10.75 | 5.15 | 4.44 | 8.19 | 8.93 | Upgrade
|
| P/OCF Ratio | 5.90 | 6.98 | 4.53 | 4.17 | 6.27 | 6.96 | Upgrade
|
| PEG Ratio | - | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 | Upgrade
|
| EV/Sales Ratio | 0.76 | 0.99 | 0.84 | 0.78 | 1.72 | 1.68 | Upgrade
|
| EV/EBITDA Ratio | 2.89 | 3.82 | 3.48 | 3.35 | 6.76 | 6.57 | Upgrade
|
| EV/EBIT Ratio | 3.29 | 4.29 | 3.93 | 3.84 | 7.52 | 6.99 | Upgrade
|
| EV/FCF Ratio | 6.90 | 8.98 | 4.30 | 4.24 | 7.75 | 8.63 | Upgrade
|
| Debt / Equity Ratio | 0.14 | 0.14 | 0.09 | 0.15 | 0.28 | 0.33 | Upgrade
|
| Debt / EBITDA Ratio | 0.73 | 0.73 | 0.46 | 0.72 | 1.45 | 1.34 | Upgrade
|
| Debt / FCF Ratio | 1.75 | 1.75 | 0.58 | 0.92 | 1.67 | 1.77 | Upgrade
|
| Net Debt / Equity Ratio | -0.18 | -0.18 | -0.18 | -0.11 | -0.03 | -0.06 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.93 | -0.93 | -0.93 | -0.55 | -0.16 | -0.25 | Upgrade
|
| Net Debt / FCF Ratio | -2.20 | -2.20 | -1.15 | -0.69 | -0.18 | -0.33 | Upgrade
|
| Asset Turnover | 0.56 | 0.56 | 0.57 | 0.63 | 0.47 | 0.62 | Upgrade
|
| Inventory Turnover | 2.08 | 2.08 | 2.14 | 2.07 | 1.34 | 1.83 | Upgrade
|
| Quick Ratio | 1.92 | 1.92 | 1.62 | 1.37 | 1.81 | 1.95 | Upgrade
|
| Current Ratio | 2.11 | 2.11 | 1.81 | 1.54 | 2.16 | 2.24 | Upgrade
|
| Return on Equity (ROE) | 14.02% | 14.02% | 15.18% | 15.06% | 13.01% | 21.89% | Upgrade
|
| Return on Assets (ROA) | 8.05% | 8.05% | 7.63% | 7.93% | 6.77% | 9.31% | Upgrade
|
| Return on Invested Capital (ROIC) | 16.18% | 17.16% | 16.81% | 16.55% | 15.82% | 22.89% | Upgrade
|
| Return on Capital Employed (ROCE) | 15.30% | 15.30% | 15.60% | 17.40% | 14.00% | 18.10% | Upgrade
|
| Earnings Yield | 17.59% | 14.88% | 18.43% | 19.48% | 9.39% | 12.15% | Upgrade
|
| FCF Yield | 10.99% | 9.30% | 19.44% | 22.51% | 12.22% | 11.20% | Upgrade
|
| Dividend Yield | 4.42% | 3.71% | 4.19% | 3.88% | 1.70% | 2.16% | Upgrade
|
| Payout Ratio | 23.17% | 23.17% | 19.39% | 14.50% | 24.19% | 15.00% | Upgrade
|
| Buyback Yield / Dilution | 2.63% | 2.63% | 2.24% | 0.62% | 0.43% | 0.21% | Upgrade
|
| Total Shareholder Return | 7.00% | 6.34% | 6.43% | 4.50% | 2.13% | 2.37% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.